Home » Newsletters » BioWorld Asia

BioWorld Asia

April 4, 2001

View Archived Issues

Micromet Raises EUR40M In Fourth Financing Round

Nasdaq Buying Part Of Easdaq In Move That Helps Biotech Firms

Transgene Decides To Refocus, Concentrate On Cancer Programs

Meristem Partners With Goodwin To Gain Foothold In U.S. Market

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

Canada Invests C$21M For Stem Cell Research Initiative

EMEA Sets Out Plans Covering Biotechnology For Next 2 Years

Hybrigenics Launches Map On Protein HIV Interactions

Other News To Note

Oxford Gene, Affymetrix Settle Microarray Patent Litigation

New Group Formed To Assess Drug Competitiveness Issues

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...